ISM

Immunology·MeSH: Hypersensitivity
143 drugs in development·73 companies·1 clinical trial

Drug Pipeline by Phase

Approved(53)
DrugCompany
Alginic Sodium Diester InjectionCHINA PHARMA HOLDINGS, INC. (CPHI)
amoxicillinMiromatrix Medical Inc. (MIRO)
apixabanMylan II B.V. (MYL)
apixabanImpax Laboratories, LLC (IPXL)
aveedEndo LP (NDOI)
azithromycinAptinyx Inc. (APTX)
azithromycinSUNSET ISLAND GROUP (SUN)
azithromycinGT Biopharma, Inc. (GTBP)
batEmergent BioSolutions Inc. (EBS)
bevyxxaPORTOLA PHARMACEUTICALS INC (PTLA)
cefepimeAtara Biotherapeutics, Inc. (ATRA)
cefepimeSeagen Inc. (SGEN)
ceftriaxoneTeva Pharmaceutical Industries Limited (TEVA)
cinacalcetDR REDDYS LABORATORIES LTD (RDY)
ciprofloxacinPrestige Consumer Healthcare Inc. (PBH)
ciprofloxacinAMARIN CORP PLCUK (AMRN)
ciprofloxacinSUNSET ISLAND GROUP (SUN)
ciprofloxacinDR REDDYS LABORATORIES LTD (RDY)
ciprofloxacinANI PHARMACEUTICALS INC (ANIP)
ciprofloxacinAltamira Therapeutics Ltd. (CYTOF)
Clarithromycin Granules and CapsulesCHINA PHARMA HOLDINGS, INC. (CPHI)
daurismoPFIZER INC (PFE)
diphenhydramineACHIEVE LIFE SCIENCES, INC. (ACHV)
doxercalciferolAmneal Pharmaceuticals, Inc. (AMRX)
emblaveoAbbVie Inc. (ABBV)
enoxaparinAmphastar Pharmaceuticals, Inc. (AMPH)
ermezaMylan II B.V. (MYL)
erythromycin lactobionateNEXUS BIOPHARMA INC (NEXS)
estradiolAmneal Pharmaceuticals, Inc. (AMRX)
exforge hctNovartis AG (NVS)
fludeoxyglucose f18BRIGHT MINDS BIOSCIENCES INC. (DRUG)
fludeoxyglucose f18Cardinal Health Inc. (CAH)
heparinPFIZER INC (PFE)
JemperliANAPTYSBIO, INC (ANAB)
korlymCORCEPT THERAPEUTICS INC (CORT)
losartanTeva Pharmaceutical Industries Limited (TEVA)
metabolic healthThorne Healthtech, Inc. (THRN)
minocyclineNEXUS BIOPHARMA INC (NEXS)
naftifineAmneal Pharmaceuticals, Inc. (AMRX)
nebivololANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomilAmneal Pharmaceuticals, Inc. (AMRX)
orlynvahIterum Therapeutics plc (ITRM)
rayaldeeREPLIGEN CORP (RGEN)
rayaldeeOPKO HEALTH, INC. (OPK)
RYTARYAmneal Pharmaceuticals, Inc. (AMRX)
sivextroCurative Biotechnology Inc (CUBT)
telmisartanInventiva S.A. (IVA)
testosteroneAmneal Pharmaceuticals, Inc. (AMRX)
testosterone enanthateNEXUS BIOPHARMA INC (NEXS)
tobramycinAmneal Pharmaceuticals, Inc. (AMRX)
UNITHROIDAmneal Pharmaceuticals, Inc. (AMRX)
yorvipathAscendis Pharma A/S (ASND)
zerbaxaCurative Biotechnology Inc (CUBT)
Phase 2(38)
DrugCompany
200-1600 µg of mbx 2109 once-weekly byMBX Biosciences, Inc. (MBX)
200-1600 µg of mbx 2109 once-weekly byMBX Biosciences, Inc. (MBX)
400 µg of mbx 2109 once-weekly byMBX Biosciences, Inc. (MBX)
400 µg of mbx 2109 once-weekly byMBX Biosciences, Inc. (MBX)
CannabidivarinUNITED THERAPEUTICS Corp (UTHR)
canvuparatideMBX Biosciences, Inc. (MBX)
cardiopetFLUOROPHARMA MEDICAL, INC. (FPMI)
CediranibASTRAZENECA PLC (AZN)
cin-107CinCor Pharma, Inc. (CINC)
cin-107 2 mg dosingASTRAZENECA PLC (AZN)
cin-107 4 mg dosingASTRAZENECA PLC (AZN)
cin-107 8 mg dosingASTRAZENECA PLC (AZN)
dt402Definium Therapeutics Inc. (DFTX)
dt402 (r-enantiomer of 3Definium Therapeutics Inc. (DFTX)
eb612Entera Bio Ltd. (ENTX)
encaleretGH Research PLC (GHRS)
GnRHENANTA PHARMACEUTICALS INC (ENTA)
gwp42006GW PHARMACEUTICALS PLC (GWPH)
Intranasal OxytocinUNITED THERAPEUTICS Corp (UTHR)
kisspeptin 112-121ENANTA PHARMACEUTICALS INC (ENTA)
leflutrozoleMereo BioPharma Group plc (MREO)
LevothyroxineCrinetics Pharmaceuticals, Inc. (CRNX)
levothyroxine sodiumXeris Biopharma Holdings, Inc. (XERS)
mbx 2109MBX Biosciences, Inc. (MBX)
ml-004/MapLight Therapeutics, Inc. (MPLT)
MM402Definium Therapeutics Inc. (DFTX)
North StarCrinetics Pharmaceuticals, Inc. (CRNX)
North StarENANTA PHARMACEUTICALS INC (ENTA)
OlaparibMerus N.V. (MRUS)
pax-101Kuvatris Therapeutics, Inc. (PXMD)
regn7508REGENERON PHARMACEUTICALS, INC. (REGN)
regn9933REGENERON PHARMACEUTICALS, INC. (REGN)
rz358 sequential group cohort 1Rezolute, Inc. (RZLT)
rz358 sequential group cohort 2Rezolute, Inc. (RZLT)
rz358 sequential group cohort 3Rezolute, Inc. (RZLT)
rz358 sequential group cohort 4Rezolute, Inc. (RZLT)
testosterone 1.62% gelGH Research PLC (GHRS)
XP-8121Xeris Biopharma Holdings, Inc. (XERS)

Compare drugs

Frequently asked questions

How many drugs are in development for ISM?

BioSniper tracks 143 drugs in development for ISM across 73 companies.

How many clinical trials target ISM?

There are 1 clinical trial targeting ISM tracked by BioSniper.

Deep-dive into ISM

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis